AOBiome was founded by James Heywood in 2012.

Who are AOBiome's investors?

AOBiome's investors include Wakestream Ventures.

How much funding has AOBiome raised?

AOBiome has disclosed $3.1M raised across 2 rounds.

Where is AOBiome headquartered?

AOBiome is headquartered in Cambridge, US.

AOBiome

Cambridge, US · Founded 2012 · 18 employees on LinkedIn · 1 known investors

AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus. Its lead candidate, B244, uses a single strain of Ammonia Oxidizing Bacteria to moderate immune response by simultaneously down-regulating multiple inflammatory markers (IL-4, IL-5, IL-13, IL-31).

Biotech Digital Health Healthtech Wellness & Fitness

Founders & leadership

AOBiome was founded in 2012 by James Heywood.

James HeywoodManager of Issuer

Spiros JamasChief Executive Officer and Manager of Issuer

Walter G. ThompsonManager

Board

Leonard BarshackManager of Issuer

Walter ThompsonManager of Issuer

Investors · 1

Wakestream VenturesGrand Rapids · $150K – $500K

Reported raises · per SEC filings

Form D private placements

$3.1M disclosed across 2 rounds · 2014–2015

▶$2.5MraisedSep 2015 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Leonard BarshackDirector
Spiros JamasExecutive Officer, Director
James HeywoodDirector
Walter ThompsonDirector

Offering amount: $15M
Amount sold: $2.5M
First sale: Sep 2015
Incorporated: Limited Liability Company, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$576.5KraisedAug 2014 · 13 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

James HeywoodExecutive Officer, Director
Spiros JamasExecutive Officer
Walter G. ThompsonDirector
Leonard BarshackDirector

Offering amount: $7.5M
Amount sold: $576.5K
First sale: Aug 2014
Incorporated: Limited Liability Company, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Mission BioCapital Platinum Program Holdings LLC18 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.

Companies competing with AOBiome for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AOBiome do?: AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus. Its lead candidate, B244, uses a single strain of Ammonia Oxidizing Bacteria to moderate immune response by simultaneously down-regulating multiple inflammatory markers (IL-4, IL-5, IL-13, IL-31).
Who founded AOBiome?: AOBiome was founded by James Heywood in 2012.
Who are AOBiome's investors?: AOBiome's investors include Wakestream Ventures.
How much funding has AOBiome raised?: AOBiome has disclosed $3.1M raised across 2 rounds.
Where is AOBiome headquartered?: AOBiome is headquartered in Cambridge, US.